Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors
- Publication date
- 1 October 2020
- Publisher
- eScholarship, University of California